Determining the causal links and clinical significance of rare genetic variants
Description: GWAS have identified many common genetic variants associated with various traits and diseases. However most of the individual effects of common variants at the trait level are very small, requiring very large sample sizes (i.e. 10's of thousands) for detection, with associations found providing low accuracy predictions of an individual's liability to disease or outcomes after treatment. Genetic effects of common variants on intermediate phenotypes, such as gene expression or protein concentrations, are often much larger than those on traits and diseases and such associations are thus often detectable in smaller samples of hundreds or thousands of individuals. Combining information from large studies of disease outcomes and smaller transcriptomic or proteomic studies in a two-sample Mendelian randomisation study can be used to provide evidence for a causal path from DNA variation through gene expression to a disease outcome. Even so, the relatively small genetic effects of common variants on phenotypic traits make them difficult to study in the small functional studies feasible in the laboratory.
Some genetic variants have larger genetic effects than those common variants detected by GWAS, but such variants are often kept at low frequency within individual pedigrees by natural selection as a consequence of their larger effects on individual fitness. Such variants are hence difficult to detect in cosmopolitan studies of unrelated individuals, but may become detectable in studies of pedigreed populations, especially where small founder population size and drift may enhance the frequency of otherwise rare variants. Nonetheless such variants are unlikely to be in LD with and hence captured by associations with SNPs on standard arrays. Rare variants of large effect are most likely to be located within or close to expressed genes. Hence using DNA sequence from the exome and adjacent regions is a good strategy to capture such variants.
In this project we propose to link proteomic data with the exome variants to detect locally (i.e. cis) acting genetic effects on protein concentrations.
Funder: Medical Research Council
Amount: £254,700
Funding type: fellowship
Start date: 2018-02-12
End date: 2021-02-11
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Funded outputs count: 27
Funder award ID: MR/R026408/1
OpenAlex ID: G4678970614